Cross-target view to feature selection: Identification of molecular interaction features in ligand-target space

Journal of Chemical Information and Modeling

Volumn 51, Issue 1, 2011, Pages 15-24

  Niijima, Satoshi ^a   Yabuuchi, Hiroaki ^a   Okuno, Yasushi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTATIONAL EFFICIENCY; DIMENSIONALITY REDUCTION; LIGANDS; MOLECULAR INTERACTIONS; MOLECULAR STRUCTURE; PREDICTIVE ANALYTICS;

CHEMOGENOMICS; COMPUTATIONAL BOTTLENECKS; CYTOCHROME P450; HIV-PROTEASE; KERNEL METHODS; MOLECULAR BASIS; TARGET BINDING; TARGET SPACE;

FEATURE EXTRACTION;

CYTOCHROME P450; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE; LIGAND;

ALGORITHM; ARTICLE; BIOLOGY; GENETICS; METABOLISM; METHODOLOGY; MUTATION; PROTEIN BINDING;

ALGORITHMS; COMPUTATIONAL BIOLOGY; CYTOCHROME P-450 ENZYME SYSTEM; HIV PROTEASE; LIGANDS; MUTATION; PROTEIN BINDING;

EID: 79952595140     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci1001394     Document Type: Article

References (49)

1. Klabunde, T. Chemogenomic approaches to drug discovery: similar receptors bind similar ligands. Br. J. Pharmacol. 2007, 152, 5-7. (Pubitemid 47339899)
2. Rognan, D. Chemogenomic approaches to rational drug design. Br. J. Pharmacol. 2007, 152, 38-52. (Pubitemid 47339898)
3. Bajorath, J. Computational analysis of ligand relationships within target families. Curr. Opin. Chem. Biol. 2008, 12, 352-358.
4. Bock, J. R.; Gough, D. A. Virtual screen for ligands of orphan G protein-coupled receptors. J. Chem. Inf. Model 2005, 45, 1402-1414. (Pubitemid 41476023)
5. Erhan, D.; L'Heureux, P.-J.; Yue, S. Y.; Bengio, Y. Collaborative filtering on a family of biological targets. J. Chem. Inf. Model. 2006, 46, 626-635.
6. Guyon, I.; Elisseeff, A. An introduction to variable and feature selection. J. Mach. Learn. Res. 2003, 3, 1157-1182.
7. Fröhlich, H.; Wegner, J. K.; Zell, A. Towards optimal descriptor subset selection with support vector machines in classification and regression. QSAR Comb. Sci. 2004, 23, 311-318. (Pubitemid 39490409)
8. Byvatov, E.; Schneider, G. SVM-based feature selection for characterization of focused com-pound collections. J. Chem. Inf. Comput. Sci. 2004, 44, 993-999.
9. Xue, Y.; Li, Z. R.; Yap, C. W.; Sun, L. Z.; Chen, X.; Chen, Y. Z. Effect of molecular de-scriptor feature selection in support vector machine classification of pharmacokinetic and toxicological properties of chemical agents. J. Chem. Inf. Comput. Sci. 2004, 44, 1630-1638.
10. Schölkopf, B.; Smola, A. J. Learning with Kernels: Support Vector Machines, Regulariza-tion, Optimization, and Beyond; MIT Press: Cambridge, MA, 2002.
11. Fukumizu, K.; Bach, F. R.; Jordan, M. I. Dimensionality reduction for supervised learning with reproducing kernel Hilbert spaces. J. Mach. Learn. Res. 2004, 5, 73-99.
12. Fukumizu, K.; Bach, F. R.; Jordan, M. I. Kernel dimensionality reduction in regression. Ann. Stat. 2009, 37, 1871-1905.
13. Hawkins, D. M. The problem of overfitting. J. Chem. Inf. Comput. Sci. 2004, 44, 1-12.
14. Schnur, D. M.; Hermsmeier, M. A.; Tebben, A. J. Are target- familyprivileged substructures truly privileged. J. Med. Chem. 2006, 49, 2000-2009.
15. Schuffenhauer, A.; Jacoby, E. Annotating and mining the ligandtarget chemogenomics knowledge space. Drug Discovery Today 2004, 2, 190-200. (Pubitemid 39349125)
16. Faulon, J.-L.; Misra, M.; Martin, S.; Sale, K.; Sapra, R. Genome scale enzyme-metabolite and drug-target interaction predictions using the signature molecular descriptor. Bioinformatics 2008, 24, 225-233.
17. Jacob, L.; Vert, J.-P. Protein-ligand interaction prediction: an improved chemogenomics ap-proach. Bioinformatics 2008, 24, 2149-2156.
18. Nagamine, N.; Sakakibara, Y. Statistical prediction of protein-chemical interactions based on chemical structure and mass spectrometry data. Bioinformatics 2007, 23, 2004-2012. (Pubitemid 47299842)
19. Strömbergsson, H.; Daniluk, P.; Kryshtafovych, A.; Fidelis, K.; Wikberg, J. E.; Kley-wegt, G. J.; Hvidsten, T. R. Interaction model based on local protein substructures generalizes to the entire structural enzyme-ligand space. J. Chem. Inf. Model 2008, 48, 2278-88.
20. Wassermann, A. M.; Geppert, H.; Bajorath, J. Ligand prediction for orphan targets using support vector machines and various target-ligand kernels is dominated by nearest neighbor effects. J. Chem. Inf. Model 2009, 49, 2155-2167.
21. Weill, N.; Rognan, D. Development and validation of a novel proteinligand fingerprint to mine chemogenomic space: application to G protein-coupled receptors and their ligands. J. Chem. Inf. Model 2009, 49, 1049-62.
22. Gretton, A.; Bousquet, O.; Smola, A. J.; Schölkopf, B. Proceedings of the Sixteenth International Conference on Algorithmic Learning Theory; Singapore, Oct. 8-11; Springer: Berlin/Heidelberg, 2005; pp 63-78.
23. Song, L.; Bedo, J.; Borgwardt, K. M.; Gretton, A.; Smola, A. Gene selection via the BAHSIC family of algorithms. Bioinformatics 2007, 23, i490-i498. (Pubitemid 47244436)
24. Li, K.-C. Sliced inverse regression for dimension reduction. J. Am. Stat. Assoc. 1991, 86, 316-327.
25. Yeh, Y.-R.; Huang, S.-Y.; Lee, Y.-J. Nonlinear dimension reduction with kernel sliced inverse regression. IEEE Trans. Knowledge Data Eng. 2009, 21, 1590-1603.
26. Guyon, I.; Weston, J.; Barnhill, S.; Vapnik, V. Gene selection for cancer classification using support vector machines. Mach. Learn. 2002, 46, 389-422. (Pubitemid 34129977)
27. Bach, F. R.; Jordan, M. I. Kernel independent component analysis. J. Mach. Learn. Res. 2002, 3, 1-48.
28. Golub, G. H.; Loan, C. F. V. Matrix Computations, 3rd ed.; Johns Hopkins University Press: Baltimore, 1996.
29. Kontijevskis, A.; Komorowski, J.; Wikberg, J. E. S. Generalized proteochemometric model of multiple cytochrome P450 enzymes and their inhibitors. J. Chem. Inf. Model 2008, 48, 1840-1850.
30. Lapins, M.; Wikberg, J. E. S. Proteochemometric modeling of drug resistance over the mu-tational space for multiple HIV protease variants and multiple protease inhibitors. J. Chem. Inf. Model 2009, 49, 1202-1210.
31. Todeschini, R.; Consonni, V. Handbook of Molecular Descriptors; Wiley-VCH: Weinheim, Germany, 2000.
32. Dragon X, version 1.2; Milano Chemometrics and QSAR Research Group: Milan, 2007.
33. MOE, version 2008.10; Chemical Computing Group Inc.: Montreal, Canada, 2008.
34. Li, Z. R.; Lin, H. H.; Han, L. Y.; Jiang, L.; Chen, X.; Chen, Y. Z. PROFEAT: a web server for computing structural and physicochemical features of proteins and peptides from amino acid sequence. Nucleic Acids Res. 2006, 34, W32-W37. (Pubitemid 44529730)
35. Leslie, C. S.; Eskin, E.; Cohen, A.; Weston, J.; Noble, W. S. Mismatch string kernels for discriminative protein classification. Bioinformatics 2004, 20, 467-476. (Pubitemid 38344326)
36. Sandberg, M.; Eriksson, L.; Jonsson, J.; Sjöström, M.; Wold, S. New chemical descriptors relevant for the design of biologically active peptides. A multivariate characterization of 87 amino acids. J. Med. Chem. 1998, 41, 2481-2491. (Pubitemid 28321898)
37. Saunders, C.; Gammerman, A.; Vovk, V. Proceedings of the Fifteenth International Conference on Machine Learning; Wisconsin, July 24-27; Morgan Kaufmann Publishers, Inc.: San Francisco, 1998; pp 515-521.
38. Vapnik, V. N. Statistical Learning Theory; John Wiley & Sons, Inc.: New York, 1998.
39. Chang, C.-C.; Lin, C.-J. LIBSVM: a library for support vector machines. http://www.csie.ntu.edu.tw/~cjlin/libsvm/.
40. de Groot, M. J. Designing better drugs: predicting cytochrome P450 metabolism. Drug Discovery Today 2006, 11, 601-606.
41. Chohan, K. K.; Paine, S. W.; Mistry, J.; Barton, P.; Davis, A. M. A rapid computational filter for cytochrome P450 1A2 inhibition potential of compound libraries. J. Med. Chem. 2005, 48, 5154-5161. (Pubitemid 41113903)
42. Kriegl, J. M.; Arnhold, T.; Beck, B.; Fox, T. Prediction of human cytochrome P450 inhibition using support vector machines. QSAR Comb. Sci. 2005, 24, 491-502. (Pubitemid 40839677)
43. Jensen, B. F.; Vind, C.; Padkjær, S. B.; Brockhoff, P. B.; Refsgaard, H. H. F. In silico predic-tion of cytochrome P450 2D6 and 3A4 inhibition using Gaussian kernel weighted k-nearest neighbor and extended connectivity fingerprints, including structural fragment analysis of inhibitors versus noninhibitors. J. Med. Chem. 2007, 50, 501-511. (Pubitemid 46239784)
44. Riley, R. J.; Parker, A. J.; Trigg, S.; Manners, C. N. Development of a generalized, quanti-tative physicochemical model of CYP3A4 inhibition for use in early drug discovery. Pharm. Res. 2001, 18, 652-655. (Pubitemid 32595794)
45. Rogers, D.; Hahn, M. Extended-connectivity fingerprints. J. Chem. Inf. Model 2010, 50, 742-754.
46. Pipeline Pilot, version 6.5.1; Accelrys, Inc.: San Diego, CA, 2007.
47. Lapins, M.; Eklund, M.; Spjuth, O.; Prusis, P.; Wikberg, J. E. S. Proteochemometric modeling of HIV protease susceptibility. BMC Bioinformatics 2008, 9, 181.
48. Muzammil, S.; Ross, P.; Freire, E. A major role for a set of nonactive site mutations in the development of HIV-1 protease drug resistance. Biochemistry 2003, 42, 631-638. (Pubitemid 36133287)
49. Rhee, S.-Y.; Fessel, W. J.; Zolopa, A. R.; Hurley, L.; Liu, T.; Taylor, J.; Nguyen, D. P.; Slome, S.; Klein, D.; Horberg, M.; Flamm, J.; Follansbee, S.; Schapiro, J. M.; Shafer, R. HI. HIIfect. Dis. 2005, 192, 456-465.